Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Gains from Investment Securities: 2021-2025

Historic Gains from Investment Securities for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $61.9 million.

  • Roivant Sciences' Gains from Investment Securities fell 133.34% to -$6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 95.05%. This contributed to the annual value of $61.9 million for FY2025, which is 475.49% up from last year.
  • According to the latest figures from FY2025, Roivant Sciences' Gains from Investment Securities is $61.9 million, which was up 475.49% from -$16.5 million recorded in FY2024.
  • In the past 5 years, Roivant Sciences' Gains from Investment Securities ranged from a high of $443.8 million in FY2022 and a low of -$17.0 million during FY2021.
  • Over the past 3 years, Roivant Sciences' median Gains from Investment Securities value was $21.2 million (recorded in 2023), while the average stood at $22.2 million.
  • As far as peak fluctuations go, Roivant Sciences' Gains from Investment Securities skyrocketed by 2,713.70% in 2022, and later crashed by 177.75% in 2024.
  • Yearly analysis of 5 years shows Roivant Sciences' Gains from Investment Securities stood at -$17.0 million in 2021, then spiked by 2,713.70% to $443.8 million in 2022, then crashed by 95.22% to $21.2 million in 2023, then slumped by 177.75% to -$16.5 million in 2024, then skyrocketed by 475.49% to $61.9 million in 2025.